{"title":"Effects of a piperazine derivative, piribedil, on exploration, locomotor activity and social behaviour in the rat","authors":"Sandra E. File","doi":"10.1016/0364-7722(81)90076-X","DOIUrl":null,"url":null,"abstract":"<div><p></p><ul><li><span>1.</span><span><p>1. The piperazine derivative, piribedil (ET495), in doses ranging from 10 to 100 mg/kg reduced locomotor activity and exploration in rats naive to the holeboard, but had less effect on exploration and was without effect on locomotor activity in rats familiar with the apparatus.</p></span></li><li><span>2.</span><span><p>2. Doses of 5–100 mg/kg disrupted the usual between-day decrement in exploration and locomotor activity, but did not change the increase in head-dipping when novel objects were introduced on the second day.</p></span></li><li><span>3.</span><span><p>3. ET495 and amphetamine counteracted each other's effects on locomotor activity, but had similar and additive effects on exploration.</p></span></li><li><span>4.</span><span><p>4. Haloperidol did not antagonise the effects of ET495.</p></span></li><li><span>5.</span><span><p>5. ET495 (0.5 & 1 mg/kg) increased social interaction between male rats when they were tested in an unfamiliar arena, but was without effect in a familiar one.</p></span></li><li><span>6.</span><span><p>6. The effects of ET495 are dependent on the animal's familiarity with the test arena, but over the dose-range tested (0.5 to 100 mg/kg) there was no evidence of low doses acting on presynaptic receptors to produce stimulation of locomotor activity or exploration. The enhanced social interaction found after low doses might reflect a presynaptic action.</p></span></li></ul></div>","PeriodicalId":20801,"journal":{"name":"Progress in neuro-psychopharmacology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"1981-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0364-7722(81)90076-X","citationCount":"12","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Progress in neuro-psychopharmacology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/036477228190076X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 12
Abstract
1.
1. The piperazine derivative, piribedil (ET495), in doses ranging from 10 to 100 mg/kg reduced locomotor activity and exploration in rats naive to the holeboard, but had less effect on exploration and was without effect on locomotor activity in rats familiar with the apparatus.
2.
2. Doses of 5–100 mg/kg disrupted the usual between-day decrement in exploration and locomotor activity, but did not change the increase in head-dipping when novel objects were introduced on the second day.
3.
3. ET495 and amphetamine counteracted each other's effects on locomotor activity, but had similar and additive effects on exploration.
4.
4. Haloperidol did not antagonise the effects of ET495.
5.
5. ET495 (0.5 & 1 mg/kg) increased social interaction between male rats when they were tested in an unfamiliar arena, but was without effect in a familiar one.
6.
6. The effects of ET495 are dependent on the animal's familiarity with the test arena, but over the dose-range tested (0.5 to 100 mg/kg) there was no evidence of low doses acting on presynaptic receptors to produce stimulation of locomotor activity or exploration. The enhanced social interaction found after low doses might reflect a presynaptic action.